Adynomine (Ability Negating Neurotoxin)

Adynomine is the medical term for a neurotoxin capable of negating the human brain's ability to manifest and control SLC-Expressive superhuman abilities. The drug is injected subcutaneously or intramuscularly through the skin and suppression of SLC-Expressive abilities takes effect within one minute. Once injected, adynomine negates abilities for 11 hours on average, with higher or lower metabolisms affecting the duration of the drug by one to two hours on either side.

Adynomine is the result of years of research and development by both the Company and later the Institute. Adynomine has existed in three forms, each substantially more refined than the next.

Adynomine I (Unavailable)

Adynomine I was created in late 2007 from the synthesis of chemicals utilized in an oral application of a select group of neurological inhibitors which eventually was further developed into the drug Adynotyline which was mass-marketed from late 2010 through 2011 and is no longer available. Adynomine I had a slow onset time of roughly 3 to 4 minutes and only lasted roughly a half an hour. In 2014 it was discovered that Adynomine I contained high concentrations of carcinogenic compounds that raised risk of cancer.

Adynomine II (Unavailable)

Major breakthroughs came in early 2009 with the development of Adynomine II by researchers at the Company. Adynomine II was liberally utilized in the Moab Federal Penitentiary, however the synthesis of the drugs new biological components were unstable and could not be kept in its concentrated form. Instead archaic pneumatic injection devices that mixed the drug on delivery with a multi-needle application were used. This application method left a distinct pock-marked scar under the chin where it was used, a defining trait of former Moab inmates.

Adynomine II was also purposefully designed to have a critical flaw in its makeup. If applied to an SLC-Expressive human with accelerated regeneration, the drug would not take full effect, and more rapidly be metabolized. While it had a 24-hour duration of use, Adynomine II suffered from intentional flaws in its construction used to undermine the security of the Moab Federal Penitentiary by elements within Pinehearst that had access to the drug's production facilities. In 2014 it was discovered that Adynomine II contained high concentrations of carcinogenic compounds that raised risk of cancer.

Adynomine III (Unavailable)

In late 2009, the Commonwealth Institute developed Adynomine III, a refined version of Adynomine II, with a 36-hour duration and onset in less than one minute. Adynomine III has none of the side-effects of the prior iterations and was in regular use by all government installations that detain Evolved. Unfortunately, the primary source of the neurotoxin in Adynomine III was harvested from Carol Praeger when she was in the custody of the Institute. Since her liberation and the fall of the Institute, Adynomine III is no longer available. In 2014 it was discovered that Adynomine III contained high concentrations of carcinogenic compounds that raised risk of cancer.

Adynomine IV (Available)

In 2015 following the conclusion of the civil war, the US-based pharmaceuticals company Helix Bioscience was able to produce Adynomine IV. The composition of Adynomine IV is from a cocktail of neurotransmitter-blocking chemical compounds created to mimic the effects the H5N10 virus had on the Suresh Linkage Complex. Unlike its predecessor, Adynomine IV has a 1 minute onset time and lasts for an average of 11 hours, depending on the subject's metabolism. Adynomine IV sometimes causes the following side-effects: insomnia, headaches, rash, blurred vision, drowsiness, agitation or nervousness, dizziness, pain in the joints or muscles, upset stomach, nausea, or diarrhea, and reduced sexual desire. Long-term Adynomine IV users who immediately cease using Adynomine IV may experience powerful migraines lasting 3–7 days, mood swings, and irregularly blunted SLC-Expressive ability function. Adynomine IV is classified as a Schedule IV Controlled Substance by the FDA.


Adynomine is available to licensed medical professionals, and law-enforcement. Individual people looking to gain access to adynomine must do so through either legitimate channels, or through black market connections. Characters seeking adynomine through legitimate channels who are not within the listed factions or licensed medical practitioners must submit a +request. Black market characters looking to illegally sell adynomine should also submit a +request.

Adynomine (Ability Negating Neurotoxin)

Currently in the keeping of:
US Government and below factions

Faction Access
Raytech SESA SZC Wolfhound Yamagato
Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License